• Male urinary dysfunction falls into three categories: voiding symptoms (affecting the bladder outlet), storage symptoms (often from an overactive bladder), and red flags requiring urgent referral

• Benign prostatic hyperplasia shares risk factors with cardiovascular disease and erectile dysfunction, suggesting a holistic approach to assessment and management

• Minimally invasive prostate surgery offers advantages, including day surgery, faster recovery, less bleeding, and better preservation of sexual function

• Healthcare professionals should refer patients when medical therapy fails to meet expectations or when red flags are present

• Early referrals and effective treatments can help patients regain their quality of life

Host: Dr David Lim | Total Time: 21 mins

Expert: A/Prof Eric Chung, Urological Surgeon

Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

See omnystudio.com/listener for privacy information.

The questions answered in this podcast are listed below.
They were compiled by GPs and health professionals around Australia.

1. Is fezolinetant (Veoza) safe for use in older populations, particularly those over 70?
2. Is fezolinetant (Veoza) listed on the PBS? If not, what is its cost?
3. Can fezolinetant (Veoza) be taken alongside other medications, such as thyroxine?
4. How long is it safe for a woman to continue using fezolinetant (Veoza)?
5. Is fezolinetant (Veoza) suitable for use during the perimenopausal stage?
6. Can fezolinetant (Veoza) be used in combination with an estrogen patch or gel for women who still experience vasomotor symptoms?
7. Is fezolinetant (Veoza) safe to use alongside other medications, such as Oxybutynin or SSRIs? Do we have any data on interactions?
8. Is fezolinetant (Veoza) safe for young women with aggressive breast cancer who are undergoing hormone therapy?
9. How should a woman transition from menopausal hormone therapy (MHT) to fezolinetant (Veoza)? Can low-dose MHT be used alongside fezolinetant (Veoza)?
10. For women who have undergone chemotherapy for breast cancer and have abnormal liver function tests post-treatment, should fezolinetant (Veoza) only be started once liver function returns to normal?
11. Should fezolinetant (Veoza) be discontinued if liver function tests become abnormal during treatment?
12. Is there any evidence that fezolinetant (Veoza) helps with memory and concentration issues in menopausal women?
13. Why does fezolinetant (Veoza) cause endometrial hyperplasia?
14. Could you confirm whether the endometrial hyperplasia observed in clinical trials was benign?
15. Is fezolinetant (Veoza) suitable for women with a personal or family history of breast cancer?
16. Is there any data on the effects of fezolinetant (Veoza) beyond 52 weeks? Were women from diverse ethnic backgrounds, beyond America and Europe, included in the trials?
17. What are the recommendations regarding the effect of fezolinetant (Veoza) on liver function? How should liver function be monitored, and when should testing be repeated or the medication stopped?
18. Can GPs prescribe fezolinetant (Veoza), or is it restricted to specialists?
19. Is fezolinetant (Veoza) appropriate for men experiencing hot flushes due to hormone blockers for prostate cancer (off-label use)?
20. Patient Case: I have a patient currently on fezolinetant (VEOZA®), Pristiq, and Tamoxifen. What would you recommend in this case?
21. Patient Case: I have a mid-40s patient suffering from frequent hot flushes every 10-15 minutes, despite being on the maximum dose of MHT. Can fezolinetant (VEOZA®) be used in combination with MHT to target these hot flushes? Also, what are your thoughts on testosterone? Some of my patients use compounded testosterone to manage their symptoms. Would this be helpful for this patient, and can testosterone be used alongside fezolinetant (VEOZA®)?
22. Patient Case: A patient started fezolinetant (VEOZA®) nearly a month ago to address almost hourly sweats and flushes. Initially, she saw a significant improvement for the first 5 days, but now the frequency and severity of symptoms have gradually returned. Is this tachyphylaxis, or should the dosage of fezolinetant (VEOZA®) be increased? Should it be used intermittently? How should I advise this patient?

Host: Dr Terri Foran | Total Time: 29 mins

Expert: Dr Rod Baber, Obstetrician and Gynaecologist

Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

See omnystudio.com/listener for privacy information.

In this Healthed lecture, Dr Shannon Thomas provides a refresher on the presenting symptoms and signs of PAD, as well as its assessment and diagnosis. He will also outline the latest management options for this condition, including the advances in endovascular surgery that are reducing the risk of leg amputation in severely affected patients.

See omnystudio.com/listener for privacy information.

In this Healthed lecture, Professor Rod Baber uses a series of case studies to discuss some of the challenges that clinicians face when managing women with menopausal symptoms. He will outline the appropriate assessment and management of symptomatic women with a history of conditions such as DVT, migraine, or cardiovascular disease, and explain how they can still access the benefits of MHT while minimising risks.

See omnystudio.com/listener for privacy information.

In this Healthed lectue, cardiologist, Professor Andrew Sindone and endocrinologist, Dr Ted Wu discuss the importance of SGLT2 inhibitors for patients with type 2 diabetes and cardiovascular disease, and the ground-breaking evidence that has seen this class of drugs now be recommended as second-line T2D treatment after metformin, particularly for its cardiovascular benefits. Importantly, the experts will also explain recent PBS changes that have improved access to SGLT2 inhibitors as well as other practical considerations associated with these medications.

See omnystudio.com/listener for privacy information.

In this Healthed podcast, Dr Fiona Chan explains that, research has now identified new antibody-mediated demyelinating diseases that have been mistaken for MS in the past. She will focus on two of these conditions in particular, pointing out how they present and in whom, and, importantly, how they can be differentiated from MS and how they should be diagnosed and managed to optimise health outcomes for the patient.

See omnystudio.com/listener for privacy information.

• Key messages delivered at the ‘So Hot Right Now’ and ‘Feeling the Heat’ meetings at the Sydney Opera House in early March 2025

• Controversies about the use of higher dose oestrogen and the potential overuse of testosterone for other than its current indications

• How these messages might translate into the management of menopause in a general practice setting

Host: Dr Terri Foran | Total Time: 45 mins

Expert: Dr Rebecca South, Women's Health General Practitioner

Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

See omnystudio.com/listener for privacy information.

In this episode:

• Nail infections are common, and it’s worthwhile to understand the potential infectious causes and triggers, such as over-washing or underlying nail tumour

• Nail infections can lead to paronychia or vice versa, causing nail deformities where infections can arise

• Treating nail infections is simple, provided the diagnosis is correct. Simple infections can be treated with topical treatment, however fungal infections may require antibiotics or anti-fungal agents

Host: Dr David Lim, GP and Medical Educator

Expert: Dr Philip Tong, Dermatologist

Total time: 21 mins

Register for our fortnightly FREE WEBCASTS

Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

See omnystudio.com/listener for privacy information.

• Healthcare professionals should recommend that patients spend time in blue spaces (oceans, rivers) and green spaces (forests, parks) for various health benefits

• Spending up to 2 hours weekly in nature (about 20 minutes daily) improves mental health, reduces depression and anxiety, lowers blood pressure, and enhances sleep quality

• Children who spend time in nature show reduced ADHD symptoms, better behaviour and improved physical development

• Nature exposure benefits all age groups, helping to reduce urban mental health issues and providing social connection for isolated individuals

• People with limited access to green spaces can create small gardens, use balcony plants, visit community gardens, or simply sit mindfully in local parks for similar benefits

Host: Dr David Lim | Total Time: 37 mins

Expert: A/Prof Vicki Kotsirilos AM, Specialist General Practitioner

Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

See omnystudio.com/listener for privacy information.

• Compression is the mainstay for managing venous leg ulcers and other lower limb wounds with oedema

• Most patients with poor arterial supply can safely use compression with proper assessment via arterial duplex ultrasound

• A key contraindication for compression therapy is significant sensory loss or neuropathy due to risk of undetected pressure injuries

• Starting with light compression (tubular bandages) allows patients to adjust before progressing to stockings or multi-layer systems

• Managing neuropathic pain with appropriate medications is crucial for ensuring compliance with compression therapy

Host: Dr Marita Long | Total Time: 40 mins

Expert: Dr Iestyn Lewis, Emergency Physician

Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

See omnystudio.com/listener for privacy information.